An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.

“This is a historic step,” says Prof. Dr. Robert Schoevers, head of psychiatry at the University Medical Center Groningen (UMCG) and principal investigator of PsyPal. “After many months of preparation, we are thrilled to begin working directly with patients.”

THIS RECRUITMENT PROCESS IS CLOSED.

[PLEASE NOTE THAT THE RECRUITMENT PROCESS FOR THIS CALL IS NOW CLOSED]

Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud (Champalimaud Foundation), a private, non-profit research institution, is opening a call for a Research Technician.

This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.

The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.